Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories. PGD offers high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides custom solutions such as cancer whole genome analysis, cancer genome germline analysis, sample preparation and sequencing, data interpretation and analysis, cancer bioinformatic analysis and ctDNA analyses, among others. The company caters to academics, biotechnology and pharmaceutical companies, and contract research organizations. PGD is headquartered in Baltimore, Maryland, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
Reasons to buy
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Personal Genome Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Personal Genome Diagnostics Inc Company Overview
- Personal Genome Diagnostics Inc Company Snapshot
- Personal Genome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Personal Genome Diagnostics Inc - Pipeline Analysis Overview
- Personal Genome Diagnostics Inc - Key Facts
- Personal Genome Diagnostics Inc - Major Products and Services
- Personal Genome Diagnostics Inc Pipeline Products by Development Stage
- Personal Genome Diagnostics Inc Pipeline Products Overview
- MutatorDETECT Assay
- MutatorDETECT Assay Product Overview
- PGDx Plasma Based Diagnostic Kit
- PGDx Plasma Based Diagnostic Kit Product Overview
- PGDx Tissue Based Diagnostic Kit
- PGDx Tissue Based Diagnostic Kit Product Overview
- PlasmaSelect-R Liquid Biopsy Test - CLIA
- PlasmaSelect-R Liquid Biopsy Test - CLIA Product Overview
- Personal Genome Diagnostics Inc - Key Competitors
- Personal Genome Diagnostics Inc - Key Employees
- Personal Genome Diagnostics Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Personal Genome Diagnostics Inc, Recent Developments
- Apr 19, 2018: Personal Genome Diagnostics TMB Analysis Used in Groundbreaking NEJM Study Showing Promising Checkpoint Inhibitor Efficacy in Early Stage Lung Cancer
- Dec 14, 2017: Liquid Biopsy Results Differed Substantially Between Two Providers
- Nov 10, 2017: U.S. Dept. of Veterans Affairs Renews and Expands Cancer Testing Contract with Personal Genome Diagnostics
- Jun 14, 2017: Personal Genome Diagnostics Awarded Department of Veterans Affairs Contract for Its PlasmaSELECT Liquid Biopsy Cancer Profiling Assay
- Jun 02, 2017: Personal Genome Diagnostics Highlights its Patent-Pending Microsatellite Instability Testing Technology as FDA Approves Keytruda for MSI Tumors
- Mar 30, 2017: Personal Genome Diagnostics Announces AACR Annual Meeting 2017 Presentations and Awards
- Mar 28, 2017: Personal Genome Diagnostics' Expanded PlasmaSELECT 64 Is First Liquid Biopsy Pan-Cancer Profiling Panel to Include MSI Analyses for Immuno-Oncology
- Mar 22, 2017: Personal Genome Diagnostics Announces Expanded Cancer Testing Contract with U.S. Department of Veteran Affairs
- Feb 01, 2017: Personal Genome Diagnostics Awarded National Cancer Institute Contract to Develop Novel Diagnostic for Immuno-Oncology Drugs
- Jan 17, 2017: Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development
- Appendix
- Methodology
- About
- Contact
- Disclaimer
List of Tables
- Personal Genome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Personal Genome Diagnostics Inc Pipeline Products by Equipment Type
- Personal Genome Diagnostics Inc Pipeline Products by Indication
- Personal Genome Diagnostics Inc, Key Facts
- Personal Genome Diagnostics Inc, Major Products and Services
- Personal Genome Diagnostics Inc Number of Pipeline Products by Development Stage
- Personal Genome Diagnostics Inc Pipeline Products Summary by Development Stage
- MutatorDETECT Assay - Product Status
- MutatorDETECT Assay - Product Description
- PGDx Plasma Based Diagnostic Kit - Product Status
- PGDx Plasma Based Diagnostic Kit - Product Description
- PGDx Tissue Based Diagnostic Kit - Product Status
- PGDx Tissue Based Diagnostic Kit - Product Description
- PlasmaSelect-R Liquid Biopsy Test - CLIA - Product Status
- PlasmaSelect-R Liquid Biopsy Test - CLIA - Product Description
- Personal Genome Diagnostics Inc, Key Employees
- Glossary
List of Figures
- Personal Genome Diagnostics Inc Pipeline Products by Equipment Type
- Personal Genome Diagnostics Inc Pipeline Products by Development Stage
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Adverum Biotechnologies Inc
- Integrated Genomics, Inc.
- Complete Genomics Inc
